NASDAQ:MYL - Mylan Stock Price, Forecast & News

Mylan trades on the NASDAQ under the ticker symbol "MYL."

Mylan NV (NASDAQ:MYL) announced its quarterly earnings data on Tuesday, November, 5th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.14 by $0.03. The company earned $2.96 billion during the quarter, compared to analysts' expectations of $3.01 billion. Mylan had a net margin of 0.42% and a return on equity of 18.80%. The business's quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the company earned $1.25 EPS. View Mylan's Earnings History.

Mylan is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Mylan.

Mylan will be holding an earnings conference call on Thursday, February 27th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

20 brokerages have issued 1 year price objectives for Mylan's shares. Their forecasts range from $18.00 to $36.00. On average, they anticipate Mylan's stock price to reach $26.92 in the next twelve months. This suggests a possible upside of 37.8% from the stock's current price. View Analyst Price Targets for Mylan.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mylan in the last year. There are currently 9 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mylan.

Media stories about MYL stock have trended somewhat positive on Wednesday, InfoTrie reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Mylan earned a news impact score of 2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Mylan.

Mylan saw a increase in short interest during the month of February. As of February 14th, there was short interest totalling 24,030,000 shares, an increase of 7.9% from the January 30th total of 22,280,000 shares. Based on an average daily trading volume, of 6,230,000 shares, the days-to-cover ratio is presently 3.9 days. Approximately 4.7% of the shares of the stock are sold short. View Mylan's Current Options Chain.

Some companies that are related to Mylan include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), The Medicines (MDCO), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX) and Corcept Therapeutics (CORT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Mylan investors own include Gilead Sciences (GILD), Teva Pharmaceutical Industries (TEVA), Alibaba Group (BABA), Allergan (AGN), Micron Technology (MU), Starbucks (SBUX), Netflix (NFLX), Intel (INTC), NVIDIA (NVDA) and General Electric (GE).

Mylan's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (4.53%), Pzena Investment Management LLC (4.03%), Geode Capital Management LLC (1.99%), AQR Capital Management LLC (1.80%), FIL Ltd (1.58%) and Bank of New York Mellon Corp (0.97%). Company insiders that own Mylan stock include Anthony Mauro, Goulds Bruce, Melina E Higgins, Paul Campbell, Rajiv Malik, Richard A Mark, Robert J Coury and Sjoerd S Vollebregt. View Institutional Ownership Trends for Mylan.

MYL stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Phoenix Holdings Ltd., Banco Santander S.A., Schroder Investment Management Group, First Trust Advisors LP, Bank of New York Mellon Corp, Amundi Pioneer Asset Management Inc. and FMR LLC. View Insider Buying and Selling for Mylan.

MYL stock was purchased by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Jacobs Levy Equity Management Inc., Pzena Investment Management LLC, Samlyn Capital LLC, Marshall Wace North America L.P., Marshall Wace LLP, FIL Ltd and Schonfeld Strategic Advisors LLC. Company insiders that have bought Mylan stock in the last two years include Melina E Higgins, Richard A Mark, Robert J Coury and Sjoerd S Vollebregt. View Insider Buying and Selling for Mylan.

Shares of MYL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MYL stock can currently be purchased for approximately $19.54.

Mylan has a market capitalization of $10.09 billion and generates $11.43 billion in revenue each year. The company earns $352.50 million in net income (profit) each year or $4.58 on an earnings per share basis. Mylan employs 35,000 workers across the globe.View Additional Information About Mylan.

The official website for Mylan is http://www.mylan.com/.

Mylan's mailing address is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. The company can be reached via phone at 724-514-1800 or via email at [email protected]